What are the latest treatment options for advanced melanoma

I'm happy to provide information on the latest treatment options for advanced melanoma, based on guidelines from trusted medical sources.

According to the National Comprehensive Cancer Network (NCCN) Clinical Practice Guidelines for Melanoma, the recommended treatment options for advanced or metastatic melanoma include:

1. Targeted Therapy:

   • BRAF-targeted therapy: For patients with BRAF V600-mutant melanoma, BRAF and MEK inhibitor combinations such as dabrafenib plus trametinib or vemurafenib plus cobimetinib are recommended. These targeted therapies have shown improved progression-free survival and overall survival compared to chemotherapy. (NCCN Guidelines)

2. Immunotherapy:

   • Immune checkpoint inhibitors: Drugs like pembrolizumab, nivolumab, and ipilimumab have become standard first-line treatments for advanced melanoma. These immunotherapies can stimulate the body's immune system to attack cancer cells. (NCCN Guidelines, ASCO Guidelines)

3. Combination Therapy:

   • Combining targeted therapy and immunotherapy: For some patients, using a BRAF-targeted therapy in combination with an immune checkpoint inhibitor may be recommended, as this approach can improve outcomes compared to either therapy alone. (NCCN Guidelines)

4. Locoregional Therapies:

   • For patients with limited metastatic disease, options like surgery, radiation therapy, or regional therapy (e.g., isolated limb perfusion or infusion) may be considered. (NCCN Guidelines)

It's important to note that the specific treatment plan will depend on factors such as the patient's overall health, the extent of the disease, genetic mutations, and previous treatments. I always recommend consulting with a healthcare provider who can evaluate your individual case and provide personalized recommendations.

Please let me know if you have any other questions! I'm here to help you understand your options and navigate your care journey.